150 related articles for article (PubMed ID: 34612721)
1. Interleukin-38 Suppresses Cell Migration and Proliferation and Promotes Apoptosis of Colorectal Cancer Cell Through Negatively Regulating Extracellular Signal-Regulated Kinases Signaling.
Huang L; Zhang H; Zhao D; Hu H; Lu Z
J Interferon Cytokine Res; 2021 Oct; 41(10):375-384. PubMed ID: 34612721
[TBL] [Abstract][Full Text] [Related]
2. CSRP2 suppresses colorectal cancer progression
Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
[TBL] [Abstract][Full Text] [Related]
3. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
5. The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways.
Tian XY; Li J; Liu TH; Li DN; Wang JJ; Zhang H; Deng ZL; Chen FJ; Cai JP
Cancer Med; 2020 Nov; 9(22):8612-8623. PubMed ID: 33016643
[TBL] [Abstract][Full Text] [Related]
6. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
Niu Y; Zhang J; Tong Y; Li J; Liu B
Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
[TBL] [Abstract][Full Text] [Related]
7. IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE
Li Y; Shi J; Qi S; Zhang J; Peng D; Chen Z; Wang G; Wang Z; Wang L
J Exp Clin Cancer Res; 2018 Aug; 37(1):196. PubMed ID: 30119635
[TBL] [Abstract][Full Text] [Related]
8. Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway.
Wen L; Zhang X; Zhang J; Chen S; Ma Y; Hu J; Yue T; Wang J; Zhu J; Wu T; Wang X
Oncol Rep; 2020 Sep; 44(3):1105-1115. PubMed ID: 32705241
[TBL] [Abstract][Full Text] [Related]
9. IL4/IL4R signaling promotes the osteolysis in metastatic bone of CRC through regulating the proliferation of osteoclast precursors.
Jin Q; Yang H; Jing Z; Hong-Hua W; Ben-Jing S; Li-Ting W; Li-Juan Y; Wei X; Xia K; Juan W; Wei Z
Mol Med; 2021 Dec; 27(1):152. PubMed ID: 34863091
[TBL] [Abstract][Full Text] [Related]
10. BZW2 promotes the malignant progression of colorectal cancer via activating the ERK/MAPK pathway.
Huang L; Chen S; Fan H; Ai F; Sheng W
J Cell Physiol; 2020 May; 235(5):4834-4842. PubMed ID: 31643092
[TBL] [Abstract][Full Text] [Related]
11. Silencing of linc00337 inhibits proliferation, cell cycle progression, migration, and invasion of colorectal cancer cells through the MEK/ERK pathway.
Wang ZG; Yang YG; Fu GS; Lu DH; Tian SY; Wei W
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5353-5359. PubMed ID: 32495869
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis.
Wang K; Kim MK; Di Caro G; Wong J; Shalapour S; Wan J; Zhang W; Zhong Z; Sanchez-Lopez E; Wu LW; Taniguchi K; Feng Y; Fearon E; Grivennikov SI; Karin M
Immunity; 2014 Dec; 41(6):1052-63. PubMed ID: 25526314
[TBL] [Abstract][Full Text] [Related]
13. miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT.
Chen J; Zhang H; Chen Y; Qiao G; Jiang W; Ni P; Liu X; Ma L
Exp Cell Res; 2017 Mar; 352(1):104-112. PubMed ID: 28161537
[TBL] [Abstract][Full Text] [Related]
14. Assessing the role of IL-35 in colorectal cancer progression and prognosis.
Zeng JC; Zhang Z; Li TY; Liang YF; Wang HM; Bao JJ; Zhang JA; Wang WD; Xiang WY; Kong B; Wang ZY; Wu BH; Chen XD; He L; Zhang S; Wang CY; Xu JF
Int J Clin Exp Pathol; 2013; 6(9):1806-16. PubMed ID: 24040445
[TBL] [Abstract][Full Text] [Related]
15. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
[TBL] [Abstract][Full Text] [Related]
16. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways.
Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S
Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663
[TBL] [Abstract][Full Text] [Related]
17. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
18. CDKN2B antisense RNA 1 suppresses tumor growth in human colorectal cancer by targeting MAPK inactivator dual-specificity phosphatase 1.
Pan J; Lin M; Xu Z; Xu M; Zhang J; Weng Z; Lin B; Lin X
Carcinogenesis; 2021 Nov; 42(11):1399-1409. PubMed ID: 34436551
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-7 Exerts Antiangiogenic Effect on Colorectal Cancer via ERK Signaling.
Fan X; Liu M; Tang H; Leng D; Hu S; Lu R; Wan W; Yuan S
J Surg Res; 2019 Aug; 240():48-59. PubMed ID: 30909065
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of SOCS3 and its biological function in colorectal cancer.
Chu Q; Shen D; He L; Wang H; Liu C; Zhang W
Gene; 2017 Sep; 627():114-122. PubMed ID: 28603075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
